According to Dr. Katzman, the motion-preserving artificial disc mimics normal human disc motion and is an excellent replacement device for failing fusions. Initially, the device was approved for single-level replacement, but the latest approval by the U.S. Food and Drug Administration includes two-level repair.
More articles on devices:
Dallen Medical announces first use of Compressyn Staple in human
Blue Belt Technologies adds Professor David Barrett to scientific advisory board
Large bone & joint devices market to reach $2B by 2020: 4 observations
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
